Spleen Stiffness Performance in the Noninvasive Assessment of Gastroesophageal Varices after Transjugular Intrahepatic Portosystemic Shunts
Table 1
Baseline characteristics of patients ().
Characteristic
Values
Age (y)
50.3 (18.75)
No. of male†
51 (50%)
Etiology†
ALD
3 (2.9)
CHF
3 (2.9)
CTPV
1 (1.0)
EHPVO
7 (6.9)
HBV
28 (27.5)
HCV
7 (6.9)
HBV and HCV
1 (1.0)
IPH
43 (42.2)
Miscellae
2 (2.0)
NAFLD
1 (1.0)
PBC
2 (2.0)
Unknown
3 (2.9)
Child-Pugh class†
A (5-6)
37 (36.3)
B (7-9)
50 (49.0)
C (10-13)
15 (14.7)
Child-Pugh score§
7 (6,9)
MELD score§
8.6 (6.4, 11.2)
2D-SWE (kPa)§
LS
12.7 (10.0, 18.3)
SS
39.8 (34.0, 46.4)
Conventional US§
Spleen size (cm)
Thickness
5.1 (4.5,5.8)
Diameters
16.5 (14.5,19.6)
Gastroesophageal endoscopy†
Mild
2 (2.0)
Moderate
10 (9.8)
Severe
89 (87.3)
Complications pre-TIPS†
Previous variceal bleeding
91 (81.3)
Acute bleeding
19 (17.0)
Massive ascites and previous variceal bleeding
10 (8.9)
Massive ascites, hydrothorax, and previous variceal bleeding
1 (0.9)
Massive hydrothorax and previous variceal bleeding
2 (1.8)
Previous treatment with endoscopic†
20 (17.9)
Previous treatment with beta-blockers†
85 (75.9)
ALD: autoimmune liver disease; CHF: congenital hepatic fibrosis; CTPV: cavernous transformation of the portal vein; EHPVO: extrahepatic portal vein obstruction; HBV: hepatitis B virus; HCV: hepatitis C virus; IPH: idiopathic portal hypertension; NAFLD: nonalcoholic fatty liver disease; PBC: primary biliary cirrhosis; MELD: model for end stage liver disease; 2D-SWE: two-dimensional shear-wave elastography; LS: liver stiffness; SS: spleen stiffness; TIPS: transjugular intrahepatic portosystemic shunt. †Data are number of findings, with the percentage in parentheses. §Data are medians, with the interquartile ranges in parentheses.
